Marie-Louise VachonM.D., M.Sc., FRCP(C)

Imsirovic H, Macphail G, Conway B, Fraser C, Borgia S, Smyth D, Wong A, Vachon ML, Webster D, Liu H, Feld J, Lee S, Cooper C,

Mixed-Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis

J Viral Hepat, 2024.

Résumé | Liens:

Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, Baker J, Pérez Marc G, Radley D, Shittu E, Glanternik J, Snaggs H, Baber J, Zachariah P, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Duron Padilla M, Richmond PC, Koury K, Schneider K, Kalinina EV, Cooper D, Jansen KU, Anderson AS, Swanson KA, Gruber WC, Gurtman A,

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

N Engl J Med, 388 (16), 2023.

Résumé | Liens:

Marathe G, Moodie EEM, Brouillette MJ, Lanièce Delaunay C, Cox J, Martel-Laferrière V, Gill J, Cooper C, Pick N, Vachon ML, Vachon ML, Walmsley S, Klein MB,

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada

Clin Infect Dis, 76 (3), 2023.

Résumé | Liens:

Marathe G, Moodie EEM, Brouillette MJ, Cox J, Cooper C, Delaunay CL, Conway B, Hull M, Martel-Laferrière V, Vachon ML, Walmsley S, Wong A, Klein MB,

Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning

BMC Med Res Methodol, 22 (1), 2022.

Résumé | Liens:

Pedersen J, Moukandja IP, Ndidi S, Sørensen AL, Koumakpayi IH, Lekana-Douki JB, Vachon ML, Weis N, Kobinger G, Fausther-Bovendo H

An adaptable platform for in-house hepatitis C serology

J Virol Methods, 308 , 2022.

Résumé | Liens:

Driedger M, Vachon ML, Wong A, Conway B, Ramji A, Borgia S, Tam E, Barrett L, Smyth D, Feld JJ, Lee SS, Cooper C

Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysis

Can Liver J, 4 (3), 2021.

Résumé | Liens:

Manion M, Lynn N, Pei L, Hammoud DA, Laidlaw E, Roby G, Metzger D, Mejia Y, Lisco A, Zelazny A, Holland S, Vachon ML, Scherer M, Bergin C, Sereti I

To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era

Clin Infect Dis, 72 (2), 2021.

Résumé | Liens:

Onofrio FQ, Cooper C, Borgia SM, Vachon ML, Ramji A, Lilly LB, Wong A, Booth J, Sattar I, Morales H, Lee S, Conway B, Feld JJ

Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry

Clin Infect Dis, 72 (11), 2021.

Résumé | Liens:

Cooper CL, Read D, Vachon ML, Conway B, Wong A, Ramji A, Borgia S, Tam E, Barrett L, Smyth D, Feld JJ, Lee S,

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

BMC Public Health, 20 (1), 2020.

Résumé | Liens:

Saeed S, Strumpf E, Moodie EEM, Wong L, Cox J, Walmsley S, Tyndall M, Cooper C, Conway B, Hull M, Martel-Laferriere V, Gill J, Wong A, Vachon ML, Klein MB,

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

Clin Infect Dis, 71 (2), 2020.

Résumé | Liens: